实用医学杂志 ›› 2023, Vol. 39 ›› Issue (8): 928-935.doi: 10.3969/j.issn.1006⁃5725.2023.08.002

• 基础研究 • 上一篇    下一篇

ANXA1在脑胶质母细胞瘤中表达上调并促进胶质母细胞瘤的恶性进展 

李梦欣 惠磊 汲乾坤 王树仁 李海明 金保哲    

  1. 新乡医学院第一附属医院神经外科(河南新乡 453000)

  • 出版日期:2023-04-25 发布日期:2023-04-25
  • 通讯作者: 金保哲 E⁃mail:13938765496@163.com
  • 基金资助:
    河南省科技攻关计划省部共建项目(编号:SBGJ2018057);河南省卫健委联合共建项目(编号:LHGJ20190445) 

ANXA1 is upregulated in glioblastoma and promoting malignant progression of glioblastoma

LI Mengxin, HUI Lei,JI Qiankun,WANG Shuren,LI Haiming,JIN Baozhe.   

  1. Department of Neurosurgery,the First Affiliated Hospital of Xinxiang Medical University,Xinxiang 453000,China

  • Online:2023-04-25 Published:2023-04-25
  • Contact: JIN Baozhe E⁃mail:13938765496@163.com

摘要:

目的 分析 ANXA1 mRNA 和蛋白在脑胶质母细胞瘤组织与正常脑组织之间的表达差异以 及 ANXA1 在脑胶质母细胞瘤的表达,及其与脑胶质母细胞瘤患者预后的关系;体外探讨 ANXA1 对脑胶质 母细胞瘤细胞系增殖、迁移、侵袭、凋亡能力的影响。方法 (1)从公共数据库获取脑胶质母细胞瘤组织 及正常脑组织的表达数据及相应的临床数据。比较脑胶质母细胞瘤组织与正常脑组织之间ANXA1 mRNA 的表达差异及 ANXA1 mRNA 高低表达组之间胶质母细胞瘤患者的生存时间差异。(2)通过人类蛋白质图 谱公共数据库获取 ANXA1 蛋白在 U251 细胞内定位;免疫组化检测脑胶质母细胞瘤组织及其对应的癌旁 组织中 ANXA1 蛋白的表达。(3)体外培养脑胶质母细胞瘤细胞系 U87 和 U251,构建敲低 ANXA1 基因表达 的小干扰 RNA(ANXA1⁃siRNA)并转染至 U87 和 U251 细胞中。qRT⁃PCR 和 Western blot 用于检测 mRNA 和 蛋白的表达。细胞计数试剂盒(CCK⁃8)、Transwell 和流式细胞术分别用于检测细胞增殖、细胞迁移和侵 袭、细胞凋亡。结果 (1)在 TCGA、Rembrandt 和 GSE16011 队列中均发现 ANXA1 mRNA 在胶质母细胞瘤 组织中表达明显上调,差异有统计学意义(P < 0.05)。另外,在这三个队列中均发现 ANXA1 mRNA 高表达 组患者总体生存时间明显低于低表达组患者(P < 0.001)。(2)qRT⁃PCR 和 Western blot 的分析结果均表明与阴性对照组相比,ANXA1⁃siRNA 组 ANXA1 的表达水平明显降低,差异均有统计学意义(P < 0.001)。 (3)CCK⁃8 检测结果表明敲低 ANXA1 表达后,U87 和 U251 细胞的增殖能力明显低于阴性对照组,差异有统计学意义(P < 0.001)。Transwell 细胞迁移检测结果表明:敲低 ANXA1 表达后 U87 和 U251 细胞的迁移能力明显低于对照组[实验组:(25.40 ± 2.70)、(11.20 ± 4.44);阴性对照组:(55.20 ± 8.70)、(32.20 ± 8.11)]; 细胞侵袭能力明显低于对照组[实验组:(19.60 ± 3.21)、(12.80 ± 4.66);阴性对照组:(43.40 ± 5.13)、(38.6 ± 7.37)]能力均明显低于阴性对照组,差异均有统计学意义(P < 0.001)。流式细胞术检测结果显示:U87 和 U251 细胞实验组凋亡细胞(11.84 ± 2.50)%、(29.96 ± 2.57)%均明显高于相应阴性对照组(7.42 ± 2.56)%、 (18.39 ± 1.89)%,差异有统计学意义(P < 0.05)。结论 ANXA1 在胶质母细胞瘤组织中表达上调并与患者 的不良预后相关。下调 ANXA1 基因表达能够抑制胶质母细胞瘤细胞的增殖、迁移及侵袭能力,促进胶质 瘤细胞的凋亡。

关键词:

膜联蛋白A1, 胶质瘤, 生存预后, 基因表达

Abstract:

Objective To analyze the expression differences of ANXA1 mRNA and protein between glio⁃ blastoma and normal brain tissue,and the relationship between ANXA1 expression in glioblastoma and prognosis of glioblastoma patients,and to investigate the effects of ANXA1 on the proliferation,migration,invasion and apoptosis of glioblastoma cell lines in vitro. Methods (1)The expression of glioblastoma tissues and normal brain tissues and corresponding clinical data were obtained from public databases. The difference of ANXA1 mRNA expression between glioblastoma tissues and normal brain tissues,and the difference of survival time of glioblastoma patients between high and low ANXA1 mRNA expression groups were compared.(2)The localization of ANXA1 protein in U251 cells was obtained from the Human Protein Atlas Public database. The expression of ANXA1 pro⁃ tein in glioblastoma tissues and adjacent tissues was detected by immunohistochemistry.(3)Glioblastoma cell lines U87 and U251 were cultured in vitro,and ANXA1⁃ siRNA knockdown ANXA1 gene expression was constructed and transferred into U87 and U251 cells. qRT⁃PCR and western blotting were used to detect mRNA and protein expression. Cell counting kit(CCK⁃8),Transwell and flow cytometry were used to detect cell proliferation,cell migration and invasion,and cell apoptosis,respectively. Results (1)ANXA1 mRNA expression was significantly up⁃regulated in glioblastoma tissues in TCGA,Rembrandt and GSE16011 cohorts,showing statistical significance (P<0.05). In addition,the overall survival time of patients with high ANXA1 mRNA expression was significantly lower than that of patients with low ANXA1 mRNA expression in all the three cohorts(P<0.001).(2)qRT ⁃PCR and western blotting showed that compared with that in the negative control group,the expression level of ANXA1 in the ANXA1⁃siRNA group was significantly decreased,and the difference was statistically significant(P<0.001). (3)CCK ⁃8 detection results showed that after knockdown of ANXA1 expression,the proliferation ability of U87 and U251 cells was significantly lower than that of negative control group,and the difference was statistically significant(P<0.001). Transwell cell migration assay showed that the migration of U87 and U251 cells was lower than that of corresponding negative control group after knockdown of ANXA1 expression(experimental group: (25.40 ± 2.70),(11.20 ± 4.44);negative control group:(55.20 ± 8.70),(32.20 ± 8.11)and invasion[experi⁃ mental group:(19.60 ± 3.21),(12.80 ± 4.66);negative control group:(43.40 ± 5.13),(38.6 ± 7.37)]were significantly lower than those of the negative control group,indicating statistical significance(P < 0.001). The results of flow cytometry showed that the apoptotic cells(11.84 ± 2.50)% and(29.96 ± 2.57)% in the U87 and U251 cell groups were significantly higher than those in the corresponding negative control group(7.42 ± 2.56)% and(18.39 ± 1.89)%,and the differences were statistically significant(P<0.05). Conclusion ANXA1 is up⁃ regulated in glioblastoma tissues and is associated with poor prognosis. Down⁃regulation of ANXA1 gene expression can inhibit the proliferation,migration and invasion of glioblastoma cells,and promote the apoptosis of glioblastoma cells.

Key words:

ANXA1, glioma, survival prognosis, gene expression